The world cannot dodge the question of global trade and consumption anymore
BRUSSELS (Reuters) - Facebook's acquisition of U.S. customer service startup Kustomer may hurt competition and boost its market power in online advertising, European Union antitrust regulators warned on Monday as they opened a full-scale investigation into the deal.
The terms of the deals were renegotiated after Phase 3 clinical trial data showed vaccines from the two companies are more effective than some rivals
Part of the problem is that global automakers design their cars, vans and motorcycles to win over well-heeled customers in the West, largely ignoring the needs of potential buyers in poorer markets
This is for for processing personal data in violation of the EU's General Data Protection Regulation (GDPR)
But the economy in the 19 countries that use the euro currency still lagged pre-pandemic levels
China says it has made alternative proposal for virus origin probe, EU pulls ahead of US in vaccinations, and other pandemic-related news across the globe
EU privacy watchdog EDPB on Wednesday gave the Irish data protection agency a month to issue a long-delayed decision on compliance by WhatsApp after its peers objected to its draft finding
SPACs list on an exchange and must use the proceeds to buy an existing or target company within a set timeframe
The European Medicines Agency has recommended authorising Moderna's COVID-19 vaccine for children aged 12 to 17, the first time the shot has been authorized for people under 18. In a decision on Friday, the EU drug regulator said research in more than 3,700 children aged 12 to 17 showed that the Moderna vaccine already given the OK for adults across Europe produced a comparable antibody response. Until now, the vaccine made by Pfizer and its German partner BioNTech has been the only option for children as young as 12 in North America and Europe. The U.S. Food and Drug Administration is currently considering whether to extend the use of the Moderna vaccine to the same age group. With global vaccine supplies still tight, much of the world still is struggling to immunize adults, and agencies including the World Health Organization have urged rich countries to donate their doses to the developing world where fewer than 2% of people have been vaccinated rather than moving on to ...
The European Union announced on Thursday that it will donate more than 200 million doses of vaccines against Covid-19 to countries with average and low incomes before the end of this year
Markets were little changed
The European Union said Thursday it will donate more than 200 million doses of COVID-19 vaccines to middle and low-income countries before the end of the year. That's double the initial amount that the 27-nation bloc had planned to deliver, mainly through COVAX, the U.N.-backed program to provide shots to poorer parts of the world. European Commission president Ursula von der Leyen said the EU takes its responsibility in helping the world fight the virus, everywhere. Vaccination is key that's why it is essential to ensure access to COVID-19 vaccines to countries worldwide." According to the EU, COVAX has so far delivered 122 million doses to 136 countries. The EU said it is also providing assistance to African countries to help them manufacture vaccines and medicines in order to reduce the continent's dependence on imports.
The Northern Ireland protocol was part of the settlement, backed by Johnson, that finally sealed Britain's bitter divorce from the bloc, four years after British voters backed leaving in a referendum.
With a key European Central Bank meeting on Thursday expected to convey a dovish tone and provide a further boost, the benchmark STOXX index of the region's 600 largest shares rose 0.5%.
Tense post-Brexit relations between Britain and the European Union face further strain on Wednesday, when the UK calls for major changes to trade rules agreed on by both sides.
Europe came under pressure to step up enforcement of its anti-money laundering rules
Democratic standards in the European Union are eroding in several member countries, particularly in Hungary and Poland where judicial independence is under threat
The vaccine did not make it to the European regulator's approved list, although it has been approved by WHO and also the UK MHRA